5-Bromopyrazolo[1,5-a]pyridine-3-carbaldehyde

Catalog No.: 
ACAHSM862
CAS No.: 
1101120-53-9
Molecular Formula: 
C8H5BrN2O
Molecular Weight: 
225.04
5-Bromopyrazolo[1,5-a]pyridine-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$212.00In stockInquiry
100mg95%$324.00In stockInquiry
250mg95%$652.00In stockInquiry
1g95%$1961.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromopyrazolo[1,5-a]pyridine-3-carbaldehyde
IUPAC Name5-bromopyrazolo[1,5-a]pyridine-3-carbaldehyde
MDL No.MFCD21365053
Molecular FormulaC8H5BrN2O
Molecular Weight225.04
SMILESO=CC1=C2C=C(Br)C=CN2N=C1
InChI KeyPDZJMEHDPABUAI-UHFFFAOYSA-N
Synonym5-bromopyrazolo[1,5-a]pyridine-3-carbaldehyde;Pyrazolo[1,5-a]pyridine-3-carboxaldehyde, 5-bromo-
CAS No.1101120-53-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAHSM862 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADTG620 route compound structure diagram
    ACADTG6201060812-84-1In Stock
  2. Then
  3. ACAHSM862 route product structure diagram
    ACAHSM8621101120-53-9In Stock
Inquiry

2. ACAHSM862 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADTG620 route compound structure diagram
    ACADTG6201060812-84-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAHSM862 route product structure diagram
    ACAHSM8621101120-53-9In Stock
Inquiry

3. ACAHSM862 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAHSM862 route product structure diagram
    ACAHSM8621101120-53-9In Stock
Inquiry

Comments (0)